Radius Health (RDUS) PT Lifted to $56 at Jefferies; Potentially Early Efficacy Data for RAD1901 at ASCO

Go back to Radius Health (RDUS) PT Lifted to $56 at Jefferies; Potentially Early Efficacy Data for RAD1901 at ASCO

Radius Health (RDUS) Reports Narrower Q4 Loss Than Expected

March 10, 2015 8:51 AM EDT

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.55), $0.08 better than the analyst estimate of ($0.63).

For earnings history and earnings-related data on Radius Health (RDUS) click here.

... More